ABT

Abbott Laboratories Healthcare - Medical Devices Investor Relations →

NO
1.1% ABOVE
↑ Moving away Was -0.3% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $109.67
14-Week RSI 34

Abbott Laboratories (ABT) closed at $110.83 as of 2026-02-02, trading 1.1% above its 200-week moving average of $109.67. The stock moved further from the line this week, up from -0.3% last week. The 14-week RSI sits at 34, indicating neutral momentum.

Over the past 2346 weeks of data, ABT has crossed below its 200-week moving average 25 times. On average, these episodes lasted 8 weeks. Historically, investors who bought ABT at the start of these episodes saw an average one-year return of +21.1%.

With a market cap of $192.9 billion, ABT is a large-cap stock. Return on equity stands at 13.2%. The stock trades at 3.8x book value.

ABT is a Dividend Aristocrat, having increased its dividend for 25 or more consecutive years. The current yield is 227.00%.

Over the past 33.2 years, a hypothetical investment of $100 in ABT would have grown to $4013, compared to $2849 for the S&P 500. That represents an annualized return of 11.8% vs 10.6% for the index — confirming ABT as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

In the past 12 months, corporate insiders have made 1 open-market purchase totaling $2,013,967.

Free cash flow has been declining at a -9.8% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: ABT vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After ABT Crosses Below the Line?

Across 23 historical episodes, buying ABT when it crossed below its 200-week moving average produced an average return of +19.2% after 12 months (median +19.0%), compared to +17.3% for the S&P 500 over the same periods. 91% of those episodes were profitable after one year. After 24 months, the average return was +42.7% vs +34.4% for the index.

Each line shows $100 invested at the moment ABT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Insider Buying Activity

1 conviction buy in the past 12 months (purchases over $500K with meaningful position increases).

DateInsiderTitleValueSharesPosition +%
2026-01-23FORD ROBERT B.Chief Executive Officer$2,013,96718,800+4.2%

Historical Touches

ABT has crossed below its 200-week MA 25 times with an average 1-year return of +21.1% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Aug 1981Sep 198146.7%+51.0%+45773.5%
Aug 1993Aug 199310.1%+22.4%+4436.6%
Jan 2000Mar 20001011.1%+43.8%+1429.3%
Jun 2002Nov 20022127.4%+27.2%+1148.8%
Nov 2002May 20032318.7%+3.4%+935.0%
May 2003May 200311.5%+11.6%+963.9%
Jul 2003Sep 200389.7%+10.4%+975.3%
Sep 2003Nov 200373.3%+17.7%+951.9%
Jan 2004Feb 200431.2%+25.8%+923.3%
Feb 2004Apr 200488.3%+25.9%+914.6%
Feb 2009Sep 20093112.9%+18.5%+614.2%
May 2010Jul 2010115.7%+11.8%+565.7%
Nov 2010Mar 2011206.5%+16.5%+556.0%
Feb 2016Feb 201621.4%+17.3%+257.2%
May 2016May 201631.8%+20.5%+249.8%
Jun 2016Jun 201632.8%+26.3%+245.9%
Oct 2016Nov 201610.4%+45.2%+235.6%
Nov 2016Jan 201763.8%+46.7%+235.0%
Sep 2022Oct 202212.6%+2.0%+22.6%
Oct 2022Nov 202234.3%+3.8%+24.2%
Feb 2023Apr 202365.5%+21.3%+17.0%
May 2023Jun 202332.0%+3.1%+13.7%
Aug 2023Dec 20231713.9%+9.3%+12.2%
Apr 2024Jul 2024155.8%+24.0%+6.9%
Jan 2026Ongoing3+2.1%Ongoing+3.2%
Average8+21.1%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02